Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL92870

LIDOFLAZINE
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1

Basic Information

ChEMBL ID CHEMBL92870
Name LIDOFLAZINE
Phase Phase II
Structure Type MOL
InChI Key ZBIAKUMOEKILTF-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Angex Clinium Lidoflazina Lidoflazine MCN-JR-7904 R 7904 R-7904
7
Targets
9
Activities
3
Assay Types
0
PK Parameters
20
Publications
7
Known Names
1
Indications

Molecular Properties

491.6
MW (Da)
5.75
ALogP
3
HBA
1
HBD
35.6
PSA (Ų)
0.41
QED
1
Ro5 Violations
9
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Stem -lazine
USAN Year 1966

Extended Properties

Molecular Formula C30H35F2N3O
MW 491.63
Aromatic Rings 3
Heavy Atoms 36
NP-Likeness -1.26

Indications

Cardiovascular Diseases

ATC Classification

C08EX01
lidoflazine
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CALCIUM CHANNEL BLOCKERS

Activity Summary

IC50 6 meas. best 7.8
Ki 2 meas. best 7.11
Kd 1 meas. best 7.5

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Voltage-gated inwardly rectifying potassium channel KCNH2
CHEMBL240
IC50 7.8 7.8 15.8 2
Oryctolagus cuniculus
CHEMBL374
Kd 7.5 7.5 31.6 1
Sodium channel alpha subunits; brain (Types I, II, III)
CHEMBL2095171
Ki 7.11 7.11 77.0 1
Equilibrative nucleoside transporter 1
CHEMBL1997
Ki 6.55 6.55 279.9 1
Sodium channel protein type 2 subunit alpha
CHEMBL3399
IC50 5.62 5.62 2400.0 1
Equilibrative nucleoside transporter 1
CHEMBL1997
IC50 5.3 5.3 4954.0 1
Unchecked
CHEMBL612545
IC50 5.03 5.03 9370.0 1
SARS-CoV-2
CHEMBL4303835
IC50 4.76 4.76 17390.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4651402 SARS-CoV-2 4
37468498 10.1038/s41467-023-40064-9 Nuclear receptor subfamily 1 group I member 2 3
17636949 10.1021/jm070311l Equilibrative nucleoside transporter 1 3
37468498 10.1038/s41467-023-40064-9 Androgen receptor 2
37468498 10.1038/s41467-023-40064-9 Beta-2 adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Beta-1 adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
- 10.6019/CHEMBL4651402 Vero C1008 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Progesterone receptor 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
1920352 10.1021/jm00114a009 Rattus norvegicus 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
38318365 10.1016/j.isci.2024.108907 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 1

Data from ChEMBL 36 via Core Engine